Stocks
News
ETFs
Economy
Currencies
Press Releases
Innate Pharma S.A. - American Depositary Shares (IPHA)
Last Price
1.8600
Change
+0.0100 (0.54%)
NASDAQ
· Last Trade: Dec 13th, 1:13 AM EST
Quote
News
Press Releases
Chart
Historical
FAQ
About
Competitors
Innate Pharma Releases Its 2026 Financial Calendar
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· December 11, 2025
Number of Shares and Voting Rights of Innate Pharma as of November 27, 2025
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· November 28, 2025
Innate Pharma to Present at Jefferies Global Healthcare Conference
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· November 17, 2025
Innate Pharma Reports Third Quarter 2025 Business Update and Financial Results
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· November 13, 2025
Innate Pharma Announces FDA Clearance to Proceed With TELLOMAK 3, a Confirmatory Phase 3 Trial of Lacutamab in CTCL
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· November 10, 2025
Innate Pharma Announces Conference Call and Webcast for Third Quarter 2025 Results and Business Updates
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· November 5, 2025
Innate Pharma to Host Analyst and Investor Event on Lacutamab on October 28, 2025
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· October 14, 2025
Innate Pharma Reports First Half 2025 Business Update and Financial Results
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· September 17, 2025
Innate Pharma Announces Its Participation in the 25th Edition of the European Midcap Event
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· September 15, 2025
Innate Pharma Announces Conference Call and Webcast for First Half 2025 Financial Results and Business Update
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· September 10, 2025
Number of Shares and Voting Rights of Innate Pharma as of September 1, 2025
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· September 2, 2025
Number of Shares and Voting Rights of Innate Pharma as of August 1, 2025
Regulatory news:
By
Innate Pharma SA
· Via
Business Wire
· August 4, 2025
Innate Pharma Announces Its Participation in the BTIG Virtual Biotechnology Conference
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· July 29, 2025
Number of Shares and Voting Rights of Innate Pharma as of July 3, 2025
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· July 4, 2025
Innate Pharma Announces Its Participation in H.C. Wainwright and Wolfe Research Healthcare Conferences
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· June 17, 2025
Innate Pharma Highlights Preclinical Antitumor Activity of IPH6501 in Diffuse Large B-Cell Lymphoma and Follicular Lymphoma at the 2025 European Hematology Association (EHA) Congress
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· June 13, 2025
Innate Pharma Announces Its Participation in Jefferies and Goldman Sachs Healthcare Conferences
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 27, 2025
Outcome of Innate Pharma’s 2025 Annual General Meeting
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 23, 2025
Innate Pharma Highlights Durable Responses to Lacutamab in Sezary Syndrome and Mycosis Fungoides
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 23, 2025
Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 19, 2025
Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 15, 2025
Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 13, 2025
Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 12, 2025
Innate Pharma announces conference call and webcast for Q1 2025 business update
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· May 6, 2025
Innate Pharma Files Its 2024 Universal Registration Document (Document d’enregistrement universel) and 2024 Annual Report on Form 20-F
Regulatory News:
By
Innate Pharma SA
· Via
Business Wire
· April 30, 2025
